Buy Semax Nasal Spray: Nobody Certifies the Bottle

Summary: The spray and the vial are two different purchases with two different failure modes, and only one of them comes with a document naming the batch you were sent.

This content is for informational purposes only and is not medical advice. Always consult a qualified healthcare provider before starting, changing, or stopping any medication.

If you came here to buy semax nasal spray, the honest first answer is that the supplier this page links sells a lyophilised 10 mg vial and does not sell a spray at all. Saying that up front costs us a sale and saves you a wrong click.

The card below is the vial, priced and dated, so you can see exactly what is and is not on offer.

Where readers actually buy it

Ascension Peptides — Semax

Research-grade Semax, tested by two outside labs and shipped from the US. The code below takes half off the vial.

Code at checkoutPEPTIDEDECK50% off
Semax · 10 mg$59.99$30.00$3.00/mgGet the 10 mg →

The published certificate for batch 30-05260628 carries a kinetic chromogenic LAL endotoxin test to USP Chapter 85, reporting under 0.20 EU/mL against a 0.5 EU/mL limit, plus a sterility screen. Buying 3, 5 or 10 takes 3%, 5% or 10% off the list price.

  • Batch certificates from two independent labs
  • Free shipping over $250
  • Ships same day if ordered before 2pm CST

What semax is, before the format argument starts

Most readers reach this site because they are on semaglutide or tirzepatide, or working out whether to be. Semax turns up in the same threads, described as a focus or drive compound, and it belongs to a different category from everything else we cover.

Semax is a synthetic heptapeptide: seven amino acids in the order Met-Glu-His-Phe-Pro-Gly-Pro. The first four are the ACTH(4-7) fragment, a short piece of adrenocorticotropic hormone, and the Pro-Gly-Pro tail is a stability modification that slows the enzymes which would otherwise take the chain apart quickly. PubChem lists it as CID 9811102, formula C37H51N9O10S, molecular weight 813.9 [1]. It was developed in Russia and carries a Russian registration, which is a fact about Russian regulation and nothing else.

It is not a GLP-1. It has no incretin activity, no effect on gastric emptying and no weight-management indication anywhere. It has no FDA approval for any indication, in any format, which includes every spray on the market. The evidence base behind it is not comparable to the trial record behind the drugs this site normally covers, and the second-hand English summaries of the Russian work are routinely quoted at a confidence the underlying studies do not support.

Buy semax nasal spray or buy the vial: what the container decides

The choice between a bottle and a vial is not a convenience preference. It settles six separate questions before you have opened the package.

The questionPre-mixed nasal sprayLyophilised 10 mg vial
Who set the concentrationWhoever filled it, usually without printing itNobody has yet
What the label commits toA bottle volume, sometimes a percentageA mass in milligrams, checkable against an assay
What sterility has to meanAn aqueous multi-dose product with a nozzle that goes back in the bottleA dry sealed powder until someone opens it
What ages in transitA solution, at whatever temperature it travelled atA powder, which is far less sensitive while sealed
What you can read before payingMarketing copy, in most of this channelA batch certificate naming the lot
Price per milligramNot calculable, because no mass is stated$3.00, from $30.00 for 10 mg

Every row runs the same direction, and none of it is an argument that the vial is safe. It is an argument that the vial is legible.

Why the nasal format became the consumer default

Three reasons, and not one of them is a safety finding.

The first is the needle. A bottle sells to everyone; a vial of powder sells to people who are prepared to do something with it. Removing the needle multiplies the addressable market, which is a commercial fact rather than a pharmacological one.

The second is the shelf it sits on. A finished solution with a dropper and a lifestyle label belongs in the consumer nootropic channel. A vial with a lot number and a research-use-only statement belongs in a different one, with different customers and much heavier disclaimers.

The third is inertia. The English-language discussion of this compound grew up around intranasal use, forum threads followed the discussion, and search demand followed the threads. By the time anyone asked what was in the bottles, the format had already won.

The format question is a sterility question, and FDA said so

This is the part that connects to the only formal statement any Western regulator has made about semax.

On its compounding safety page, content current as of 22 April 2026, the FDA records its concern that compounded drugs containing semax may pose a risk for immunogenicity for certain routes of administration, due to the potential for aggregation and peptide-related impurities, and states that it lacks sufficient information to know whether the drug would cause harm if administered to humans [2]. Read the emphasis. The regulator's worry is explicitly route-dependent, and choosing a format is choosing a route.

Aggregation means peptide molecules clumping into larger structures an immune system can read as foreign. It is a solution problem far more than a powder problem, and it gets worse with time, warmth and agitation. A bottle that was filled at an unknown date, shipped at an unknown temperature and sat on a shelf for an unknown period is a solution problem with three unknowns in it.

The second issue is microbiological. Water at room temperature, in a multi-dose container whose nozzle repeatedly touches a mucous membrane and goes back in the bottle, is an environment that dry powder does not create. Licensed nasal products deal with this through a documented preservative system and a battery of chemistry and controls testing that FDA's own guidance for nasal spray products lays out in detail [4]. A consumer semax spray is not held to that guidance, and it almost never tells you what preservative it uses or whether it uses one.

A bottle has no per-milligram figure

There is a smaller, duller problem that catches more buyers than the sterility argument does: you cannot price a spray.

A vial states 10 mg. Divide by what you paid and you get a number that compares against every other vial in the market. A bottle states 30 mL, or 0.1%, or nothing at all, and none of those convert into total peptide without a piece of information the listing did not give you. Two sprays at the same price can differ by a factor you have no way to calculate, and the seller who states least often looks cheapest.

That is why our semax price breakdown is built entirely on the per-milligram column. It is the only figure in this market that survives contact with a second vendor, and the spray channel is structured so that it does not exist.

What the vial's certificate answers that a spray listing does not

The lot currently behind the card is batch 30-05260628, certified by Kovera Labs on 15 June 2026 under report KVR-2026-E848E0. It reports 99.886% purity by reversed-phase HPLC against a stated specification of greater than 98%, identity confirmed by LC-MS, net content of 11.23 mg in a vial labelled approximately 10 mg, bacterial endotoxin below 0.20 EU/mL against a 0.5 EU/mL acceptance limit by kinetic chromogenic LAL assay in accordance with USP Chapter 85, a rapid microbial sterility screen returning no growth over a two-day incubation, and an ICP-MS panel with lead, arsenic, cadmium and mercury all under their limits [3].

The endotoxin and sterility lines are the interesting ones, because they are the only part of FDA's stated concern a buyer outside the laboratory can actually verify. They are also a batch question rather than a product question: this vendor's February 2026 certificates carry neither test, on Semax and on the neighbouring Selank alike, and the June batches carry both. We went through the same point on the Selank nasal spray page and the assays its February certificate never ran. Read every certificate on the product page rather than only the clickable one.

None of that is a safety guarantee, and it would be dishonest to sell it as one. The sterility line in particular is a rapid two-day screen, and the report itself notes that full USP Chapter 71 testing may be required for regulatory compliance. It is one batch. It answers a manufacturing question about that batch and says nothing whatever about the human data FDA points out does not exist. If you want the longer version of why endotoxin keeps being the hinge in these arguments, we set it out on the NAD+ injection page, where sterility is the entire question.

What this page is not going to cover

Nothing here explains how to prepare, reconstitute, concentrate, fill or administer anything. That is not squeamishness about liability. There is no version of those instructions that is not dosing guidance for a compound with no approved indication and, by the regulator's own account, no adequate human safety information. If a page offers you that alongside a buy button, notice which of the two it is really there to support.

Common questions about buying semax nasal spray

Can I buy semax nasal spray from the supplier linked on this page?
No. Ascension Peptides lists semax as a 10 mg lyophilised vial at $59.99, or $30.00 with the code PEPTIDEDECK. There is no spray in that catalogue. This page says so rather than sending you to the wrong product and hoping you do not notice.
Is a semax spray safer because there is no needle?
It removes one risk and introduces others. A multi-dose aqueous bottle carries a microbiological problem dry powder does not have, and solutions favour the aggregation FDA's warning specifically names. It is a different failure mode, not a smaller one.
Why do spray listings not state milligrams?
Some do. Many state a volume or a percentage instead, which leaves you unable to work out what you have or what you paid per unit. Treat a missing mass as a defect in the listing rather than a formatting choice, because every comparison downstream depends on it.
Is any semax nasal spray FDA approved?
No. There is no FDA-approved semax product in any format for any indication. Semax was nominated for the 503A bulks list, was placed in category 2 under the interim policies while the agency evaluated it, and the nomination was then withdrawn, leaving it on no current category list at all.
What should I ask a spray seller before ordering?
The total peptide mass in the bottle, the lot number, the preservative system, the diluent, the fill date, and whether a batch certificate exists that names that lot. Vague answers mean the product is undocumented, whatever the label design suggests.
If the vial is better documented, why does anyone buy the spray?
Because it arrives ready and the vial does not. That is a genuine advantage and this page is not pretending otherwise. The trade is that everything you would want to check has already been decided for you by someone who did not write it down.

The short version

To buy semax nasal spray is to buy a solution at a concentration you did not choose, in a container that usually states no mass, no lot and no preservative, from a channel that publishes almost no testing. The vial is dry powder with more work left to do, and on batch 30-05260628 it comes with a certificate reporting 99.886% purity, an endotoxin result under 0.20 EU/mL against a 0.5 EU/mL limit, and a rapid sterility screen with no growth, none of which the earlier February batch carried. FDA's stated concern about this peptide is immunogenicity from aggregation and peptide-related impurities, described as route-dependent, so the format is not a detail sitting beside that concern. It is the concern.

We earn a commission if you buy through the card above. That is disclosed on the card and in our disclaimer, in line with the FTC endorsement guides [5].

References

  1. PubChem Compound Summary for CID 9811102, Semax, National Library of Medicine
  2. FDA, Certain Bulk Drug Substances for Use in Compounding May Present Significant Safety Risks, content current as of 04/22/2026
  3. Kovera Labs, Certificate of Analysis, Semax 10 mg, batch 30-05260628, report KVR-2026-E848E0, certified 15 June 2026
  4. FDA, Nasal Spray and Inhalation Solution, Suspension, and Spray Drug Products: Chemistry, Manufacturing, and Controls Documentation, guidance for industry
  5. FTC, The Endorsement Guides: What People Are Asking